| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/18/2008 | WO2008103378A3 Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
| 12/18/2008 | WO2008101017A3 Glucagon/glp-1 receptor co-agonists |
| 12/18/2008 | WO2008098216A3 Compositions and methods to prevent cancer with cupredoxins |
| 12/18/2008 | WO2008094510A3 Methods of modulating immune function |
| 12/18/2008 | WO2008086296A3 Acid ceramidase and cell survival |
| 12/18/2008 | WO2008080153A3 A novel protein kinase c therapy for the treatment of acute lung injury |
| 12/18/2008 | WO2008080112A3 New fusion molecule based on novel taa variant |
| 12/18/2008 | WO2008076933A3 Long acting proteins and peptides and methods of making and using the same |
| 12/18/2008 | WO2008076490A3 Histophilus somni antigens, compositions and methods of use |
| 12/18/2008 | WO2008073392A3 Compositions and methods for cardiac tissue protection and regeneration |
| 12/18/2008 | WO2008073312B1 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 12/18/2008 | WO2008045766A3 Method for treating skin |
| 12/18/2008 | WO2008033820A3 Modifications of cupredoxin derived peptides and methods of use thereof |
| 12/18/2008 | WO2008021896A8 Therapeutic methods for neuropathic pain |
| 12/18/2008 | WO2007103182A3 Compostions and methods for administering gdnf ligand family proteins |
| 12/18/2008 | WO2007100795A3 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions |
| 12/18/2008 | WO2007098716A8 Compounds analogous to growth hormone peptide secretagogues and preparations containing them |
| 12/18/2008 | WO2007096859A9 Protection of the retina against laser injury by adnf peptides such as nap and sal |
| 12/18/2008 | WO2007095345A3 Methods and compositions for regulation of neurological conditions |
| 12/18/2008 | WO2007089601A9 Nogo receptor antagonists |
| 12/18/2008 | US20080313753 Compositions and Methods for Improving Heart Function |
| 12/18/2008 | US20080312421 Use of A33 antigens and JAM-it |
| 12/18/2008 | US20080312418 Antibody Specific for Human 4-1BB Receptor |
| 12/18/2008 | US20080312410 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 12/18/2008 | US20080312409 antiapoptosis agents; transduction domains |
| 12/18/2008 | US20080312407 Glycopeptide phosphonate derivatives |
| 12/18/2008 | US20080312263 Pharmaceutical compositions for the prevention and treatment of atherosclerosis |
| 12/18/2008 | US20080312179 High level expression of recombinant human erythropoietin having a modified 5'-UTR |
| 12/18/2008 | US20080312178 Human G-Protein Receptor HGBER32 |
| 12/18/2008 | US20080312161 Compounds For Stabilizing Factor VII Polypeptide Formulations |
| 12/18/2008 | US20080312160 Method of treating enteritis, intestinal damage, and diarrhea from c. difficile with an a2a adenosine receptor agonist |
| 12/18/2008 | US20080312159 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 12/18/2008 | US20080312158 Semaphorin Gene Family |
| 12/18/2008 | US20080312157 Gip analog and hybrid polypeptides with selectable properties |
| 12/18/2008 | US20080312156 In-Situ Crosslinkable Elastin-Like Polypeptides for Defect Filling in Cartilaginous Tissue Repair |
| 12/18/2008 | US20080312155 modified metastin containing aza-glycine, methyl arginine and N-acetyl tyrosine amino acids; cancer metastasis suppressing activity, a cancer growth suppressing activity |
| 12/18/2008 | US20080312154 Administration of adipocytokine and adiponectin for treating headache and methods of diagnosing headache by measuring adiponectin |
| 12/18/2008 | US20080312153 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 12/18/2008 | US20080312152 Glycosylated Probnp |
| 12/18/2008 | US20080312151 Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone |
| 12/18/2008 | US20080312150 Treatment and analysis of proliferative disorders |
| 12/18/2008 | US20080312149 Health Food and Pharmaceutical Composition for Amelioration of Disease Induced by Metabolic Disorder in Cartilage |
| 12/18/2008 | US20080312148 the protein is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b) |
| 12/18/2008 | US20080312147 Compositions and Methods for the Regulation of Hair Growth |
| 12/18/2008 | US20080312146 METH1 and METH2 Polynucleotides and Polypeptides |
| 12/18/2008 | US20080312145 Agent for Regulating Bone Formation |
| 12/18/2008 | US20080312144 Peptides for the Treatment of Herpes Virus Infections |
| 12/18/2008 | US20080312143 Modified Cdna for High Expression Levels of Factor VIII and Its Derivatives |
| 12/18/2008 | US20080312142 Composition for Increasing Body Height |
| 12/18/2008 | US20080312141 Peptide ligands for prostate specific antigen |
| 12/18/2008 | US20080312140 Compositions and Methods for Preventing or Treating Hiv Infection |
| 12/18/2008 | US20080312139 In an injectable form and to be administered through infiltrations inside and around cutaneous chronic ischemic ulcerative wounds as to prevent diabetic limb amputation |
| 12/18/2008 | US20080312138 Erythropoietin complementation or replacement |
| 12/18/2008 | US20080312137 Fed Batch Culture Methods for Streptococci |
| 12/18/2008 | US20080312136 Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions |
| 12/18/2008 | US20080312135 Mixtures of drug-oligomer conjugates comprising polyethylene glycol, uses thereof, and methods of making same |
| 12/18/2008 | US20080312134 Vesicles for active macromolecule delivery |
| 12/18/2008 | US20080312133 Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders |
| 12/18/2008 | US20080312132 Composition for animal consumption |
| 12/18/2008 | US20080312131 Regeneration of Chromatographic Stationary Phases |
| 12/18/2008 | US20080312130 Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the same |
| 12/18/2008 | US20080312129 Use of Mas G-Protein-Coupled Receptor Agonists and Antagonists, as Apoptotic-Activity Modulators for Study, Prevention and Treatment of Diseases |
| 12/18/2008 | US20080312128 Cellular Biomarker Antioxidant Assay and Uses Thereof |
| 12/18/2008 | US20080312127 Host Cell Comprising a Vector for Production of Proteins Requiring Gamma-Carboxylation |
| 12/18/2008 | US20080312102 Cytokine Binding Domains |
| 12/18/2008 | US20080311655 Heterodimeric fusion protein for use in the treatment of allergies and metastatic disease; cytokine linked to an antibody; nucleic acid encoding a fusion protein comprising an immunoglobulin (Ig) moiety linked by a peptide bond to the p35 subunit of interleukin-12 |
| 12/18/2008 | US20080311652 Nucleic acids encoding Melanoma-associated antigen C2 (MAGE-C2); for provoking a cytolytic T cell response; for determining if a cell presents a Human Leukocyte Antigen(HLA) molecule on its surface; diagnostic and therapeutic assays; tumor monitoring |
| 12/18/2008 | US20080311642 Methods of Purifying Chondroitinase and Stable Formulations Thereof |
| 12/18/2008 | US20080311622 Activatable recombinant neurotoxins |
| 12/18/2008 | US20080311608 Antagonist of the oncogenic activity of the protein MDM2, and use thereof in the treatment of cancers |
| 12/18/2008 | US20080311584 desirable for identification of animals having or having a predisposition for increased muscle mass that can be used to produce food products, including bovine, porcine, ovine, avian and piscine species; influence hypertrophic and hyperplastic muscle development |
| 12/18/2008 | US20080311223 Injectable polymer-lipid blend for localized drug delivery |
| 12/18/2008 | US20080311220 Method for producing demineralized bone matrix easily releasing bone morphogenetic protein and method for extracting bone morphogenetic protein using demineralized bone matrix by irradiation |
| 12/18/2008 | US20080311216 Epidermal Growth Factor Composition, A Process Therefor and Its Application |
| 12/18/2008 | US20080311214 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides |
| 12/18/2008 | US20080311199 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311198 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311192 Enteric-Coated Glucosinolates And Beta-Thioglucosidases |
| 12/18/2008 | US20080311190 Thrombin-Free Biological Adhesive and Use Thereof as a Medicament |
| 12/18/2008 | US20080311185 Deregulated Genes and/or Processes in Inflammatory Arthritis |
| 12/18/2008 | US20080311184 Method for developing, testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
| 12/18/2008 | US20080311161 Compositions and Methods for Enhanced Gastrointestinal Stability of Oligopeptides and Polypeptides |
| 12/18/2008 | US20080311139 Plant Produced Vaccine for Amebiasis |
| 12/18/2008 | US20080311132 Human Complement C3 Derivates with Cobra Venom Factor-Like Function |
| 12/18/2008 | US20080311130 Integrin Alpha L I Domain Mutants with Increased Binding Affinity |
| 12/18/2008 | US20080311126 Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of Cancer |
| 12/18/2008 | US20080311125 Scytovirin Domain 1 Related Polypeptides |
| 12/18/2008 | US20080311124 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/18/2008 | US20080311123 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/18/2008 | US20080311120 Autocrine growth factor receptor antibodies and methods |
| 12/18/2008 | US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof |
| 12/18/2008 | US20080311116 Process for the Determination of Inflammatory Process and Pharmaceutical Compositions for the Treatment Thereof |
| 12/18/2008 | US20080311114 Use of morphogenic proteins to treat human disc disease |
| 12/18/2008 | US20080311112 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders |
| 12/18/2008 | US20080311110 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease |
| 12/18/2008 | US20080311109 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/18/2008 | US20080311108 Polypeptides |
| 12/18/2008 | US20080311105 Reversibly Inactivated Acidified Plasmin |
| 12/18/2008 | US20080311104 Stabilized thrombin compositions |
| 12/18/2008 | US20080311103 Anti-Inflammatory Peptides and Methods of Use Thereof |